ELOVL1 and COVID-19: Furthermore, ELOVL1 deficiency can lead to neurological defects such as hypomyelination [103] that would render the neuronal firing slow and less efficient and, therefore, could explain the fatigue experienced by COVID-19 patients, particularly in long COVID.